Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate - PubMed (original) (raw)
. 1997 Jan 10;272(2):843-51.
doi: 10.1074/jbc.272.2.843.
Affiliations
- PMID: 8995372
- DOI: 10.1074/jbc.272.2.843
Free article
Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate
G Huyer et al. J Biol Chem. 1997.
Free article
Abstract
Vanadate and pervanadate (the complexes of vanadate with hydrogen peroxide) are two commonly used general protein-tyrosine phosphatase (PTP) inhibitors. These compounds also have insulin-mimetic properties, an observation that has generated a great deal of interest and study. Since a careful kinetic study of the two inhibitors has been lacking, we sought to analyze their mechanisms of inhibition. Our results show that vanadate is a competitive inhibitor for the protein-tyrosine phosphatase PTP1B, with a Ki of 0.38+/-0.02 microM. EDTA, which is known to chelate vanadate, causes an immediate and complete reversal of the inhibition due to vanadate when added to an enzyme assay. Pervanadate, by contrast, inhibits by irreversibly oxidizing the catalytic cysteine of PTP1B, as determined by mass spectrometry. Reducing agents such as dithiothreitol that are used in PTP assays to keep the catalytic cysteine reduced and active were found to convert pervanadate rapidly to vanadate. Under certain conditions, slow time-dependent inactivation by vanadate was observed; since catalase blocked this inactivation, it was ascribed to in situ generation of hydrogen peroxide and subsequent formation of pervanadate. Implications for the use of these compounds as inhibitors and rationalization for some of their in vivo effects are considered.
Similar articles
- Mechanism of pervanadate stimulation and potentiation of insulin-activated glucose transport in rat adipocytes: dissociation from vanadate effect.
Shisheva A, Shechter Y. Shisheva A, et al. Endocrinology. 1993 Oct;133(4):1562-8. doi: 10.1210/endo.133.4.8404595. Endocrinology. 1993. PMID: 8404595 - Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes.
Li J, Elberg G, Shechter Y. Li J, et al. Biochim Biophys Acta. 1996 Jul 24;1312(3):223-30. doi: 10.1016/0167-4889(96)00038-9. Biochim Biophys Acta. 1996. PMID: 8703991 - Use of vanadate as protein-phosphotyrosine phosphatase inhibitor.
Gordon JA. Gordon JA. Methods Enzymol. 1991;201:477-82. doi: 10.1016/0076-6879(91)01043-2. Methods Enzymol. 1991. PMID: 1943774 Review. No abstract available. - Inhibitors of protein tyrosine phosphatase 1B (PTP1B).
Taylor SD. Taylor SD. Curr Top Med Chem. 2003;3(7):759-82. doi: 10.2174/1568026033452311. Curr Top Med Chem. 2003. PMID: 12678843 Review.
Cited by
- Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.
Levina A, McLeod AI, Pulte A, Aitken JB, Lay PA. Levina A, et al. Inorg Chem. 2015 Jul 20;54(14):6707-18. doi: 10.1021/ic5028948. Epub 2015 Apr 23. Inorg Chem. 2015. PMID: 25906315 Free PMC article. - Protein tyrosine phosphatase 1B deficiency potentiates PERK/eIF2α signaling in brown adipocytes.
Bettaieb A, Matsuo K, Matsuo I, Wang S, Melhem R, Koromilas AE, Haj FG. Bettaieb A, et al. PLoS One. 2012;7(4):e34412. doi: 10.1371/journal.pone.0034412. Epub 2012 Apr 3. PLoS One. 2012. PMID: 22509299 Free PMC article. - Ovalbumin Antigen-Specific Activation of Human T Cell Receptor Closely Resembles Soluble Antibody Stimulation as Revealed by BOOST Phosphotyrosine Proteomics.
Chua XY, Salomon A. Chua XY, et al. J Proteome Res. 2021 Jun 4;20(6):3330-3344. doi: 10.1021/acs.jproteome.1c00239. Epub 2021 May 21. J Proteome Res. 2021. PMID: 34018748 Free PMC article. - Src kinase-mediated phosphorylation stabilizes inducible nitric-oxide synthase in normal cells and cancer cells.
Tyryshkin A, Gorgun FM, Abdel Fattah E, Mazumdar T, Pandit L, Zeng S, Eissa NT. Tyryshkin A, et al. J Biol Chem. 2010 Jan 1;285(1):784-92. doi: 10.1074/jbc.M109.055038. Epub 2009 Oct 29. J Biol Chem. 2010. PMID: 19875457 Free PMC article. - The control of phosphatidylinositol 3,4-bisphosphate concentrations by activation of the Src homology 2 domain containing inositol polyphosphate 5-phosphatase 2, SHIP2.
Batty IH, van der Kaay J, Gray A, Telfer JF, Dixon MJ, Downes CP. Batty IH, et al. Biochem J. 2007 Oct 15;407(2):255-66. doi: 10.1042/BJ20070558. Biochem J. 2007. PMID: 17672824 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous